BMO Capital Maintains Market Perform on Qorvo, Raises Price Target to $105

BMO Capital analyst Ambrish Srivastava maintains Qorvo (NASDAQ:QRVO) with a Market Perform and raises the price target from $90 to $105.

BMO Capital analyst Ambrish Srivastava maintains Qorvo (NASDAQ:QRVO) with a Market Perform and raises the price target from $90 to $105.

Total
0
Shares
Related Posts
Read More

Canadian Marijuana Company Cronos Expands Into UK After Setting Up In Germany’s Nascent Market

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday that it's expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW Pharma.The Toronto-based cannabis company has partnered with a distributor of prescribed medicinal cannabis products in the UK after years of investing in research and development, tissue culture, and its cannabis genetics breeding program.The debut in the UK follows the company's expansion in Germany and Australia last year, after successfully expanding across Canada and Israel.

CRON